Elmiron and Infusion related reaction - from FDA reports


Summary

Infusion related reaction is found among people who take Elmiron, especially for people who are female, 40-49 old also take medication Remicade, and have Crohn's disease. This review analyzes which people have Infusion related reaction with Elmiron. It is created by eHealthMe based on reports of 3,148 people who have side effects when taking Elmiron from FDA , and is updated regularly.

What to expect?

If you take Elmiron and have Infusion related reaction, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Elmiron and have Infusion related reaction

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Sep, 13, 2017

3,148 people reported to have side effects when taking Elmiron.
Among them, 10 people (0.32%) have Infusion related reaction


Number of reports submitted per year:

Could Elmiron cause Infusion related reaction?

Gender of people who have Infusion related reaction when taking Elmiron *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Infusion related reaction when taking Elmiron *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 14.29 %
  • 40-49: 71.43 %
  • 50-59: 14.29 %
  • 60+: 0.0 %

Top conditions involved for these people *:

  • Rheumatoid Arthritis (6 people, 60.00%)
  • Crohn's Disease (6 people, 60.00%)
  • Ulcerative Colitis (4 people, 40.00%)
  • Hormone Replacement Therapy (4 people, 40.00%)
  • Depression (4 people, 40.00%)

Top co-used drugs for these people *:

  • Remicade (6 people, 60.00%)
  • Mercaptopurine (4 people, 40.00%)
  • Lexapro (4 people, 40.00%)
  • Depakote (4 people, 40.00%)
  • Asacol (4 people, 40.00%)

Top other side effects for these people *:

  • Fatigue (6 people, 60.00%)
  • Vision Blurred (5 people, 50.00%)
  • Ocular Hyperaemia (4 people, 40.00%)
  • Migraine (4 people, 40.00%)
  • Hyperhidrosis (4 people, 40.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Infusion related reaction when taking Elmiron?

Expand the study to include all drugs with the same ingredients

Infusion related reaction and drugs with ingredients of pentosan polysulfate sodium.

Expand the study to include reports from both FDA and eHealthMe

Infusion related reaction and Elmiron from FDA and eHealthMe reports

Elmiron

Elmiron has active ingredients of pentosan polysulfate sodium. It is often used in interstitial cystitis (ic). (latest outcomes from Elmiron 3,400 users)

Infusion related reaction

Infusion related reaction has been reported by people with rheumatoid arthritis, crohn's disease, ulcerative colitis, multiple sclerosis, ankylosing spondylitis (latest reports from 23,829 Infusion related reaction patients).

Browse all side effects of Elmiron

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Infusion related reaction

Infusion related reaction

Could your condition cause Infusion related reaction

Infusion related reaction

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Elmiron and have Infusion related reaction.

Questions to the study

More questions >

User reviews to the study

More reviews >